conferenceMonday May 13, 2019

Strategic Alliance Management Congress May 13-15, 2019 Philadelphia, PA

Register Today
Vantage Training Areas of Expertise

Advancing Pharmaceuticals Through Collaborations and Partnerships

Now in its sixteenth year, the Strategic Alliance Management Congress will again unite senior alliance management, business development, project management, technology transfer, and licensing professionals to network, discuss case studies, and share the components that cultivate successful partnerships. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders advancing the art of Alliance Management.

The program will focus on best practices and success stories through case studies and co-presentations. Special attention will also be paid to unique alliances that go beyond a traditional pharma-pharma or pharma-biotech collaboration. We’ll hear from competitors working together on combination therapies, a company that chose to spin off some of its most successful assets into a brand-new company, a patient advocacy collaborator, and academics collaborating with pharma. One of the biggest drivers of change in alliance management is the field of oncology; the program will feature two focused talks on oncology alliances. Stuart Kliman and Ben Siddall of Vantage Partners will offer a keynote on the changing BioPharma partnering landscape.

 

For more information, visit alliancemanagementcongress.com/us

› Mention 1912VP to Save 10% off of your Conference Registration courtesy of Vantage Partners!

Learn more and register today!

Click here

KEYNOTE PRESENTATION: The Changing BioPharma Partnering Landscape: Implications for Alliance Management
Presented by Stuart Kliman and Ben Siddall

The life sciences partnering landscape is rapidly changing, leading to markedly different types of alliances and relationships across the value chain and drug development lifecycle. These show up in a multitude arenas and are all appropriately tagged with different names: “beyond the pill” partnerships, digital trial alliances, external innovation, real world evidence, and the like. In this discussion, Vantage will share our latest thinking about how the landscape is indeed evolving and the implications of that on partner choice making, partnership business models, and, of course, on the focus and necessary new capabilities of alliance management organizations.